At a glance
What is it—and why does it matter?
Sermorelin is categorized here with GHRH analogues, i.e., peptides designed to mimic GHRH activity.
Sources for this introduction: [1]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
Sermorelin is categorized here with GHRH analogues, i.e., peptides designed to mimic GHRH activity.
- Source records
- 2
- Independent studies
- 2
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“growth hormone-releasing hormone analogues (e.g., CJC-1295, Sermorelin)”
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. · Abstract
pubmed:41880199:39c6683290a1:39c6683290a1 - supports · Source-backed record
“growth hormone secretagogues like ipamorelin, CJC-1295, tesamorelin, sermorelin, and AOD-9604”
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. · Abstract
pubmed:41490200:ea14d075ddfc:ea14d075ddfc
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 15 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (9), assurance_score_below_0.72 (5), current_regulatory_source_required (2), extraction_ambiguity (18), high_risk_requires_regulatory_or_two_independent_sources (5), no_direct_support (14)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. ↗
pubmed · published 2026-01-01 · retrieved 2026-08-25T22:43:25Z
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. ↗
pubmed · published 2026-07-01 · retrieved 2026-08-26T08:42:26Z
Publication history and provenance
Version 6 · Automated assessment · 2026-08-28T12:18:09Z
56114ee239519ba4469faeb93261155c2852ef2e98203c5e281e882be7a8c60a